Dr. Richard Furman Discusses Treatment Options for Patients with CLL in Panel Discussion

Recently, Dr. Richard Furman participated in an OncLive hosted, multi-part panel discussion on currently available treatment options for patients with CLL. The first episode of the panel discussion is embedded below.

Other episodes of the panel discussion include “First-Line Treatment Selection in CLL” and “Safety and Efficacy of Obinutuzumab in CLL“.

A complete listing of trials at Weill Cornell Medical College for patients with lymphoma can be found here.

Author: lymphomaprogram

Located on the Upper East Side of New York City, the Lymphoma Program at Weill Cornell Medical College/NewYork Presbyterian Hospital is internationally recognized for our efforts to enable patients with non-Hodgkin lymphoma, Hodgkin disease and related disorders to have the best possible clinical outcome, including cure when possible.

Post a Comment

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

%d bloggers like this: